Pfizer paid docs $35 million in last half of 2009

Share this article:
Pfizer paid out $35 million to 4,500 healthcare professionals in the second half of 2009, the company reported.

The figures cover payments, meals and “non-monetary educational items” worth $25 or more and totaling $500 or more during the six-month period, including compensation for speaking and consulting, CME and conducting clinical trials.

Around 44% of the reported payments went to approximately 250 academic medical centers and other research organizations for clinical trials, the company said, accounting for $15.3 million that covered recruitment, coordination and execution of clinical trials and completion of “compliance activities.”

Pfizer reviewed more than 180,000 transactions and consulted patients, researchers and healthcare professionals on the format of its report, which can be viewed in a database on its website. The company will provide full-year 2010 data on March 31, 2011, and, in compliance with an agreement last year to settle government charges that it improperly marketed Bextra, will include the value of all financial interactions including non-monetary items like meals and educational items.

The report represents Pfizer's first public disclosure of payments to professionals and institutions that test and prescribe its products. Pfizer said it's the first to report payments to doctors for overseeing clinical trials. The healthcare law requires similar disclosure starting in 2013.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features


Reimagining healthcare? We want to hear about it.
 
Submit nominations here for MM&M's first-ever list of the Top 40 Healthcare Transformers

Email Newsletters

MM&M inVISION

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Upward Move: Jose Rivera

Upward Move: Jose Rivera

Jose Rivera. EVP, account director, Concentric